Relationship of dopamine of the nucleus accumbens with intra-infralimbic apomorphine microinjection

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 6, 2013, Pages 743-750

  Alimoradian, Abbas ^a   Sajedianfard, Javad ^b   Baha Aldini Beigy, Faegheh ^c   Panjehshahin, Mohammad Reza ^c   Owji, Ali Akbar ^d  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apomorphine; Dopamine; Microdialysis; The nucleus accumbens; The prefrontal cortex

Indexed keywords

APOMORPHINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; MICRODIALYSIS; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STEREOTYPY;

EID: 84880292178     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Broersen LM, Heinsbroek RPW, de Bruin, JPC, Olivier B. Effects of local application of dopaminergic drugs into the medical prefrontal cortex of rats on latent inhibition. Biol Psychiatry 1996; 40:1083-1090.
2. Goldstein M, Deutch AY. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J 1992; 6:2413-2421.
3. Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 1996; 93:1325-1329.
4. Tzschentke TM. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 2001; 63:241-320.
5. Henze DA, Gonzalez-Burgos GR, Urban NN, Lewis DA, Barrionuevo G. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J Neurophysiol 2000; 84:2799-2809.
6. Phillips AG, Ahn S, Floresco SB. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 2004; 24:547-553.
7. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74:1-57.
8. Heidbreder CA, Groenewegen HJ. The medial prefrontal cortex in the rat: evidence for a dorso- Ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003; 27:555-579.
9. Marcotte ER, Pearson DM, Srivastava LK. Animal model of schizophrenia: a critical review. J Psychiatry Neurosci 2001; 26:395-410.
10. Hedou G, Homberg J, Feldon J, Heidbreder CA. Expression of sensitization to amphetamineand dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal Cortex. Neuropharmacology 2001; 40:366-382.
11. Tzschentke TM, Schmidt WJ. Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug induced conditioned place preference and behavioural sensitization. Eur J Neurosci 1999; 11:4099-4109.
12. Bassareo V, Di Chiara G. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 1999; 89:637-641.
13. Charara A, Grace AA. Dopamine receptor subtypes selectively modulate excitatory afferents from the hippocampus and amygdala to rat nucleus accumbens neurons. Neuropsychopharmacology 2003; 28:1412-1421.
14. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1998; 85:5274-5278.
15. Narita M, Takagi M, Aoki K, Kuzumaki N, Suzuki T. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats. J Neurochem 2003; 86:273-282.
16. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 2003; 23:1879-1885.
17. You ZB, Tzschentke TM, Brodin E, Wise RA. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci 1998; 18:6492-6500.
18. Hosseini M, Alaei H A, Eslamizade MJ, Saffarzade F. Effect of morphine self-administration on water and food intake in rat. Iran J Basic Med Sci 7002; 10:169-175.
19. Ananth J, Burgoyne KS, Gadasalli R, Aquino S. How do the atypical antipsychotics work?. J Psychiatry Neurosci 2001; 26:385-394.
20. Heidbreder C, Feldon J. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 1998; 29:310-322.
21. Sellings LHL, Clarke PBS. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 2003; 23:6295-6303.
22. Karreman M, Moghaddam B, The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem 1996; 66:589-598.
23. Alimoradian A, Baha-aldini Beigy F, Sajedianfard J, Panjehshahin MR. The study of apomorphine effects and heterogeneity in the medial prefrontal cortex on dopaminergic behaviors of rats. Iran J Basic Med Sci 2009; 11:205-214.
24. Sajedianfard J, Khatami S, Semnanian S, Naghdi N, Jorjani M. In vivo measurement of noradrenaline in the locus coeruleus of rats during the formalin test: A microdialysis study. Eur J Pharmacol 2005; 512:153-156.
25. Sharp T, Zetterstrom T In vivo measurement of monoamine neurotransmitter release using brain microdialysis. In: Stampford JA editor, Monitoring neuronal activity: A practical approach. London: Oxford University Press; 1992.p.147-179.
26. Beyer CE, Steketee JD. Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat. Psychopharmacology 2000; 151:211-218.
27. Chen NNH, Pan WHT. Regulatory effects of D2 receptors in the ventral tegmental area on the mesocorticolimbic dopaminergic pathway. J Neurochem 2000; 74:2576-2582.
28. Ichikawa J, Meltzer HY. R(+)-8-OH-DPAT, a serotonin1A receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J Pharmacol Exp Ther 1999; 291:1227-1232.
29. Jackson ME, Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 2001; 21:676-681.
30. Klitenick MA, Taber MT, Fibiger HC. Effects of chronic haloperidol on stress-and stinulation-induced increases in dopamine release: tests of the depolarization block hypothesis. Neuropsychopharmacology 1996; 15:424-428.
31. Taber MT, Das S, Fibiger HC. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 1995; 65:1407-1410.
32. Tolu P, Masi F, Leggio B, Scheggi S, Tagliamonte A, De Montis MG, et al. Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 2002; 27:410-420.
33. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 3rd ed. New York: Academic Press; 1997.
34. Ventura R, Alcaro A, Mandolesi L, Puglisi-Allegra S. In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens. J Neurochem 2004; 89:494-502.
35. Amanlou M, Siadat SD, Norouzian D, Aghasadeghi MR, Fathi-Moghaddam H, Piryaei M, et al. Effect of dexamethasone on striatal neurotransmissions in the rats subjected to parkinson's disease animal model. Iran J Basic Med Sci 2011; 14:107-115.
36. Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology 2003; 28:34-44.
37. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 2004; 29:72-80.
38. Azizi Malekabadi H, Alaei H, Oryan S. The effect of exercise (Treadmill running) on glutamate concentration variation of hippocampal dentate gyrus in the intact and morphine dependent male rats. Iran J Basic Med Sci 2007; 9:250-259.
39. Kosowski AR, Liljequist S. The NR2B-selective N-Methyl-D-aspartate receptor antagonist Ro 25-6981 [(+)-(R *,S*)-α-(4-Hydroxyphenyl)-β-methyl-4-phenylmethyl)-1-piperidine Propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens. J Pharmacol Exp Ther 2004; 311:560-567.
40. Lindblom J, Opmane B, Mutulis F, Mutule I, Petrovska R, Klusa V, et al. The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport 2001; 12:2155-2158.
41. Barrot M, Marinelli M, Abrous DN, Rougé-Pont F, Le Moal M, Piazza PV Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex. Eur J Neurosci 1999; 11:1155-1166.
42. King D, Finlay JM. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress. Brain Res 1997; 767:192-200.
43. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of Rats, monkeys and humans. Cereb Cortex 2000; 10:206-219.
44. Porrino LJ, Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb Cortex 2000; 10:326-333.
45. Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U. A direct comparasion of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 1987; 401:322-330.
46. Gray JA. Integrating Schizophrenia. Schizophr Bull 1998; 24:249-266.
47. Hedou G, Feldon J, Heidbreder CA Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferents to subterriotories of the nucleus accumbens. Eur J Pharmacol 1999; 372 (2): 143-155.
48. Fetsko LA, Xu R, Wang Y. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Res 2003; 967:191-200.
49. Presti MF, Gibney BC, Lewis MH. Effects of intrastriatal administration of selective dopaminergic ligands on spontaneous stereotypy in mice. Physiol Behav 2004; 80:433-439.
50. Feenstra MGP, Botterbiom MHA, van Uum JFM. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J Neurochem 1998; 70:1104-1113.
51. del Arco A, Mora F. Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat. J Neural Transm 2005; 112:97-109.
52. Grobin AC, Deutch AY. Dopaminergic regulation of extracellular γ- Aminobutyric Acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 1998; 285:350-357.
53. Jackson ME, Frost AS, Moghaddam B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens. J Neurochem 2001; 78:920-923.
54. Matsumoto M, Kanno M, Togashi H, Ueno K, Otani H, Mano Y, et al. Involvement of GABA-A receptors in the regulation of the prefrontal cortex on dopamine release in the rat dorsolateral striatum. Eur J Pharmacol 2003; 482:177-184.
55. Mitchell JB, Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci 1992; 12:3609-3618.
56. Sorg BA, Li NA, Wu WR. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. J Pharmacol Exp Ther 2001; 297:501-508.
57. Zavitsanou K, Cranney J, Richardson R Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav 1999; 63:55-61.
58. Doherty MD, Gratton A. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Brain Res 1996; 715:86-97.
59. King D, Zigmond MJ, Finlay JM. Effects of dopamine depletion in the medial prefrontal cortex on the stress- induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 1997; 77:143-153.
60. Carr DB, Sesack SR Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 2000; 20:3864-3873.
61. Thompson TL, Moss RL. In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex. Brain Res 1995; 686:93-98.
62. Zhu ZT, Wu WR, Fu Y, Jin GZ. I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release. Acta Pharmacol Sin 2000; 21:663-667.
63. Deutch AY. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl 1992; 36:61-89.
64. Deutch AY, Clark WA, Roth RH. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 1990; 52:311-315.